Intranasal stimulation for treatment of meibomian gland disease and blepharitis
US10918864B2 · kind B2 · utility
2Cited by
191References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 2, 2017 |
| Grant date | Feb 16, 2021 |
| Priority date | — |
| Expiry date | May 2, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/36034
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Described here are devices, systems, and methods for treating meibomian gland disease and/or blepharitis by providing intranasal stimulation. Generally, the devices may deliver electrical stimulation to the nasal mucosa. Intranasal stimulation may unblock obstructed meibomian glands and increase the lipid content of tears, both acutely during stimulation and subsequent to intranasal stimulation. The methods may include an initial round of stimulation to unblock obstructed meibomian glands, and subsequent shorter rounds of stimulation to cause meibum secretion and maintain the open glands.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.